Cargando…
Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate
The inverse relationship of plasma bilirubin levels with liver fat accumulation has prompted the possibility of bilirubin as a therapeutic for non-alcoholic fatty liver disease. Here, we used diet-induced obese mice with non-alcoholic fatty liver disease treated with pegylated bilirubin (bilirubin n...
Autores principales: | Hinds, Terry D., Creeden, Justin F., Gordon, Darren M., Stec, Donald F., Donald, Matthew C., Stec, David E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775678/ https://www.ncbi.nlm.nih.gov/pubmed/33390979 http://dx.doi.org/10.3389/fphar.2020.594574 |
Ejemplares similares
-
Rats Genetically Selected for High Aerobic Exercise Capacity Have Elevated Plasma Bilirubin by Upregulation of Hepatic Biliverdin Reductase-A (BVRA) and Suppression of UGT1A1
por: Hinds, Terry D., et al.
Publicado: (2020) -
Biliverdin Reductase A (BVRA) Knockout in Adipocytes Induces Hypertrophy and Reduces Mitochondria in White Fat of Obese Mice
por: Stec, David E., et al.
Publicado: (2020) -
Bilirubin, Renal Hemodynamics, and Blood Pressure
por: Stec, David E., et al.
Publicado: (2012) -
Suppressing Hepatic UGT1A1 Increases Plasma Bilirubin, Lowers Plasma Urobilin, Reorganizes Kinase Signaling Pathways and Lipid Species and Improves Fatty Liver Disease
por: Bates, Evelyn A., et al.
Publicado: (2023) -
Bilirubin, a new therapeutic for kidney transplant?
por: Sundararaghavan, Vikram L., et al.
Publicado: (2018)